LED device and lamp

By incorporating multiple chipsets and fluorescent colloids into LED devices, independent control and brightness adjustment of each chip component are achieved, solving the problems of narrow spectral coverage and poor light quality in spectral therapy devices, and improving the consistency of treatment effects and brightness uniformity.

CN224139394UActive Publication Date: 2026-04-17JIANGXI MTC OPTOELECTRONICS CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
JIANGXI MTC OPTOELECTRONICS CO LTD
Filing Date
2025-01-20
Publication Date
2026-04-17

AI Technical Summary

Technical Problem

Existing spectral therapy equipment has a narrow spectral coverage, poor LED light quality, and large differences in peak brightness across different wavelengths, which affects the therapeutic effect.

Method used

Design an LED device including a bracket and multiple chip groups disposed within the bracket. A partition divides a receiving slot into independent sub-receiving slots, and different phosphors are disposed in each sub-receiving slot to achieve independent control and brightness adjustment of each chip assembly. The phosphors are used to form a lens to adjust the light path and ensure consistent brightness of light of different wavelengths.

Benefits of technology

It achieves the interaction of different wavelengths of light, improves the consistency of treatment effects and the uniformity of brightness, and enhances the therapeutic effect of spectral therapy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224139394U_ABST
    Figure CN224139394U_ABST
Patent Text Reader

Abstract

The utility model provides an LED device and a lamp, and relates to the technical field of semiconductors, the LED device comprises a support, and a first chipset, a second chipset and a third chipset which are arranged in the support, a containing groove is arranged in the support, and the first chipset, the second chipset and the third chipset are arranged in the containing groove. Two parallel partition plates are arranged in the containing groove to divide the containing groove into three independent sub-containing grooves, and the first chip set, the second chip set and the third chip set are arranged at the bottoms of the sub-containing grooves respectively. A plurality of fluorescent colloids sequentially cover the first chip set, the second chip set and the third chip set, and all the fluorescent colloids at least partially protrude out of the sub-containing grooves to form lens parts. The LED device provided by the utility model solves the problem that the LED treatment effect of spectrum rehabilitation treatment in the prior art is poor.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This utility model relates to the field of LED technology, and in particular to an LED device and a lamp. Background Technology

[0002] Red and near-infrared light are considered part of the life spectrum because red light waves can easily penetrate the human body to reach pathogens, reducing inflammation, killing bacteria, improving protein coagulation, promoting blood circulation, and enhancing immunity and metabolism. With technological advancements and improved living standards, people's understanding of health and wellness is deepening. People are exploring the use of artificial and natural light to optimize bodily functions, promote cellular metabolism, and maintain homeostasis, making the importance of spectral therapy self-evident.

[0003] Existing spectral therapy devices typically use red LEDs with wavelengths of 630-660nm to irradiate the human body for therapeutic effects. However, these devices have narrow spectral coverage and poor LED light quality, significantly reducing their therapeutic efficacy. Furthermore, while some existing spectral therapy devices use multiple wavelengths for modulation, the peak brightness differences between these wavelengths after combination result in varying degrees of effectiveness, thus impacting the overall therapeutic outcome. Utility Model Content

[0004] Therefore, the purpose of this utility model is to provide an LED device and lamp, which aims to solve the problem of poor LED treatment effect in the existing spectral therapy.

[0005] The LED device proposed in this utility model includes a bracket and a first chip group, a second chip group, and a third chip group disposed within the bracket. The bracket has a receiving groove, and the receiving groove is divided into three independent sub-receiving grooves by two parallel partitions. The first chip group, the second chip group, and the third chip group are respectively placed at the bottom of the sub-receiving grooves. The first chip group, the second chip group, and the third chip group are respectively covered by a plurality of fluorescent colloids, and all the fluorescent colloids at least partially protrude from the sub-receiving grooves to form lens portions.

[0006] The aforementioned LED device utilizes multiple chip groups with different wavelengths, allowing each chip group to be independently controlled. This enables the chip components to work together, emitting light of different wavelengths to achieve various therapeutic effects. Furthermore, by using accommodating slots and partitions to separate the chip components, and by placing different fluorescent adhesives within each sub-accommodating slot to cover each chip component, the light emission effect of each chip group can be adjusted using the fluorescent adhesives, thereby achieving brightness adjustment for different wavelengths of light. Additionally, the fluorescent adhesive protrudes from the sub-accommodating slots to form lens sections. By adjusting the structure and shape of these lens sections in conjunction with the parameters of the fluorescent adhesives, efficient adjustment of the light emission effect in different chip component areas can be achieved. This ensures that the different wavelengths of light emitted by each chip group work together to achieve different therapeutic effects, while also ensuring consistent brightness across different wavelengths, thus guaranteeing the consistency of the therapeutic effect. Therefore, this invention solves the problem of poor therapeutic effects in existing spectral therapy LED treatments.

[0007] In addition, the LED device proposed according to this utility model may also have the following additional technical features:

[0008] Preferably, the chip in the first chip group is a first low blue light chip, and the fluorescent colloid covering the first chip group is provided with cyan phosphor and yellow-green phosphor so that the first chip group area of ​​the bracket emits blue light, cyan light or yellow-green light.

[0009] Preferably, the second chip group includes a red light chip, a first near-red light chip, and a second near-red light chip. The fluorescent colloid covering the second chip group is transparent, so that the second chip group area of ​​the bracket emits red light within a preset wavelength range.

[0010] Preferably, the chip in the third chip group is a second low blue light chip, and the fluorescent colloid covering the third chip group contains yellow phosphor so that the third chip group area of ​​the bracket emits golden light.

[0011] Preferably, the receiving groove has a circular cross-section, and the partition divides the receiving groove into a first sub-receiving groove, a second sub-receiving groove, and a third sub-receiving groove. The second sub-receiving groove is rectangular and centrally located, and the first sub-receiving groove and the second sub-receiving groove are crescent-shaped and symmetrically located on both sides of the second sub-receiving groove.

[0012] Preferably, the first chipset, the second chipset, and the third chipset are respectively disposed at the bottom of the first sub-accommodating slot, the second sub-accommodating slot, and the third sub-accommodating slot.

[0013] Preferably, the cross-sectional area of ​​the receiving groove gradually increases from one end near the bottom of the receiving groove to the other end.

[0014] Preferably, the red light chip, the first near-red light chip, and the second near-red light chip are all located on the same anode plate, and the red light chip, the first near-red light chip, and the second near-red light chip are respectively connected to an independent cathode plate via wires.

[0015] Preferably, all the lens portions have different outer contours to adjust the brightness of the light emitted by each region of the first chip group, the second chip group, and the third chip group.

[0016] In addition, this utility model also provides a lamp, which includes the above-mentioned LED device. Attached Figure Description

[0017] Figure 1 This is a schematic diagram of the structure of an LED device proposed in one embodiment of the present invention;

[0018] Figure 2 for Figure 1 A schematic diagram of the structure behind the hidden lens section;

[0019] Figure 3 for Figure 1 Schematic diagram of the structure after hiding the fluorescent colloid;

[0020] Figure 4 for Figure 3 Schematic diagram of the structure after the support is hidden;

[0021] Figure 5 This is a therapeutic spectrum of an LED device proposed in one embodiment of the present invention.

[0022] Explanation of key component symbols:

[0023] support 10 First chipset 20 Second chipset 30 Third chipset 40 Container slot 11 partition 12 Fluorescent colloids 50 Lens section 51 First Sub-accommodation Slot 111 Second sub-accommodation slot 112 Third Sub-accommodation Slot 113 anode plate 60 cathode plate 70

[0024] The following detailed description, in conjunction with the accompanying drawings, will further illustrate this utility model. Detailed Implementation

[0025] To facilitate understanding of this utility model, a more complete description of it will be given below with reference to the accompanying drawings. Several embodiments of this utility model are shown in the drawings. However, this utility model can be implemented in many different forms and is not limited to the embodiments described herein. Rather, these embodiments are provided so that the disclosure of this utility model will be more thorough and complete.

[0026] It should be noted that when a component is said to be "fixed to" another component, it can be directly on the other component or there may be an intervening component. When a component is said to be "connected to" another component, it can be directly connected to the other component or there may be an intervening component. The terms "vertical," "horizontal," "left," "right," and similar expressions used in this document are for illustrative purposes only.

[0027] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. The term "and / or" as used herein includes any and all combinations of one or more of the associated listed items.

[0028] Please see Figures 1 to 5 The image shows an LED device according to an embodiment of the present invention, including a bracket 10 and a first chipset, a second chipset 30, and a third chipset 40 disposed within the bracket 10, wherein:

[0029] The bracket 10 has a receiving groove 11, and two parallel partitions 12 in the receiving groove 11 divide the receiving groove 11 into three independent sub-receiving grooves. The first chip group, the second chip group 30 and the third chip group 40 are respectively placed at the bottom of the sub-receiving grooves. Multiple fluorescent colloids 50 are sequentially covered on the first chip group 20, the second chip group 30 and the third chip group 40. All fluorescent colloids 50 protrude at least partially from the sub-receiving grooves to form lens portions 51.

[0030] Understandably, by using multiple chipsets with different wavelengths, each chipset can be independently controlled, thereby achieving a coordinated effect between the chip components. This allows the LED device to emit light of different wavelengths in combination to achieve different therapeutic effects. Furthermore, by setting up receiving slots 11 and partitions 12, each chip component is separated and independent. Different fluorescent adhesives are placed in each sub-receiving slot to cover each chip component, allowing the light emission effect of each chipset to be adjusted via the fluorescent adhesive, thus achieving brightness adjustment of different wavelengths of light. Additionally, the fluorescent adhesive protrudes from the sub-receiving slot to form a lens portion 51. By adjusting the structure and shape of the lens portion 51 and coordinating it with the parameters of the fluorescent adhesive, efficient adjustment of the light emission effect in different chip component areas can be achieved. This ensures that the different wavelengths of light emitted by each chipset area work together to achieve different therapeutic effects, and also ensures that the brightness of the light emitted by different wavelengths in each area is consistent, thus ensuring the consistency of the effect of each wavelength of light and guaranteeing the therapeutic effect. Therefore, this invention solves the problem of poor therapeutic effect of LED therapy in existing spectral therapy technologies.

[0031] Specifically, the chip within the first chipset is a first low-blue-light chip. The phosphor colloid 50 covering the first chipset contains cyan phosphor and yellow-green phosphor to cause the first chipset region of the support 10 to emit blue, cyan, or yellow-green light. As an example, and not a limitation, in some optional embodiments, the wavelength of the low-blue light is 455nm-465nm, the wavelength of the cyan phosphor is 490nm-495nm, and the wavelength of the yellow-green phosphor is 522nm-525nm. Preferably, in a specific implementation, the wavelength of the first low-blue-light chip is 460nm, the wavelength of the cyan phosphor is 492nm, and the wavelength of the yellow-green phosphor is 522nm. The combination of the first blue-light chip and the phosphor colloid doped with two types of phosphors results in the emitted light having an oil-controlling and bean-suppressing effect.

[0032] Additionally, the second chip assembly 30 includes a red light chip, a first near-red light chip, and a second near-red light chip. The fluorescent colloid 50 covering the second chip assembly 30 is transparent, allowing the second chip assembly 30 region of the scaffold 10 to emit red light within a preset wavelength range. As an example, and not a limitation, in some optional embodiments, the wavelength of the red light chip is 650nm-660nm, the wavelength of the first near-red light chip is 935nm-945nm, and the wavelength of the second near-red light chip is 1060nm-1068nm. The longer wavelength 650nm-700nm red light is readily absorbed by mitochondria, increasing the activity of mitochondrial catalase, promoting metabolism, increasing glycogen content, increasing protein synthesis, and increasing adenosine triphosphate (ATP) breakdown, thereby enhancing cell regeneration and promoting wound and ulcer healing. It also increases the phagocytic activity of white blood cells, enhancing the body's immune function; 660nm low-energy red light irradiation increases fibroblast cell activity and enhances cell healing ability; the mechanism of action of 940nm-1064nm low-energy infrared light on skin rejuvenation involves increasing collagen production and reducing collagen degradation to aid skin recovery. It has an increased effect on fibroblasts, increasing collagen production by reducing cell death, increasing vascular perfusion, and enhancing the expression of bFGF and TGF. The 940nm semiconductor laser can penetrate the skin and is selectively absorbed by the veins, while the skin remains intact.

[0033] Specifically, the chip within the third chipset 40 is a second low blue light chip, and the fluorescent colloid 50 covering the third chipset 40 contains yellow phosphor to cause the area of ​​the third chipset 40 of the support 10 to emit golden light. As an example, and not a limitation, in some optional embodiments, the wavelength of the yellow phosphor is 580nm-600nm. Preferably, in a specific implementation, the wavelength of the second low blue light chip is 450nm, and the wavelength of the cyan phosphor is 590nm. The combination of the two forms golden light, which helps soothe the skin and lighten melanin. Furthermore, as... Figure 5 The figure shown is a spectrum of light emitted by an LED device in one embodiment. The horizontal axis represents wavelength and the vertical axis represents light intensity.

[0034] Furthermore, the receiving groove 11 has a circular cross-section. The partition 12 divides the receiving groove 11 into a first sub-receiving groove 111, a second sub-receiving groove 112, and a third sub-receiving groove 113. The second sub-receiving groove 112 is rectangular and centrally located. The first sub-receiving groove 111 and the third sub-receiving groove 113 are crescent-shaped and symmetrically located on both sides of the second sub-receiving groove 112. The receiving groove 11 has a circular cross-sectional area, and the partition 12 divides the receiving groove 11 into a centrally located rectangular sub-receiving groove and two symmetrically located crescent-shaped sub-receiving grooves. By setting the receiving groove 11 to be circular, the light emitted by the LED device is point-like, thereby allowing for convenient adjustment of the light distribution and effect of the lamp by reasonably adjusting the number and position of the LED devices in the lamp.

[0035] Specifically, the first chip group 20, the second chip group 30, and the third chip group 40 are respectively located at the bottom of the first sub-accommodating slot 111, the second sub-accommodating slot 112, and the third sub-accommodating slot 113. The second chip group 30 contains a larger number and variety of chips, thus requiring more space. Furthermore, based on usage requirements, the red light emitted by the second chip group 30 is the primary means of spectral therapy. Therefore, the second chip group 30 is positioned in the central location to facilitate synergistic effects between the second chip group 30 and the light from the other two chip components.

[0036] Furthermore, the cross-sectional area of ​​the receiving groove gradually increases from one end near the bottom of the receiving groove 11 to the other end. By tilting the partition 12 and the sidewalls of the receiving groove 11, the light emission angle of each chip group is made larger, thereby improving the illumination range of the LED device.

[0037] Specifically, the red light chip, the first near-red light chip, and the second near-red light chip are all located on the same anode plate 60, and are connected to independent cathode plates 70 via wires. This common-electrode design allows for individual control of different chips within a relatively small space, improving space utilization.

[0038] Furthermore, all lens portions 51 have different outer contours to adjust the brightness of the light emitted from each region of the first chip group, the second chip group 30, and the third chip group 40. In addition to adjusting the light emission brightness of each chip group region by adjusting the viscosity of the fluorescent adhesive and the phosphor, the brightness adjustment effect can also be achieved by adjusting the shape of the lens portion 51 on the outside of the fluorescent adhesive 50, thereby adjusting the light path of the light at each chip group region.

[0039] In summary, the LED device in the above embodiments of this utility model utilizes multiple chip groups with different wavelengths, allowing each chip group to be independently controlled. This enables the interconnection between the various chip components, allowing the LED device to emit light of different wavelengths in coordination to achieve different therapeutic effects. Furthermore, by setting the receiving groove 11 and the partition 12, the various chip components are separated and independent. Different fluorescent adhesives are placed in each sub-receiving groove to cover each chip component, allowing the light emission effect of each chip group to be adjusted using the fluorescent adhesive, thereby achieving brightness adjustment of different wavelengths of light. Additionally, the fluorescent adhesive protrudes from the sub-receiving groove to form a lens portion 51. By adjusting the structure and shape of the lens portion 51 and coordinating it with the parameters of the fluorescent adhesive, efficient adjustment of the light emission effect of different chip component areas can be achieved. This ensures that the different wavelengths of light emitted by each chip group area coordinate to achieve different therapeutic effects, and also ensures that the brightness of the light emitted by different wavelengths in each area is consistent, thus ensuring the consistency of the effect of each wavelength of light and guaranteeing the therapeutic effect. Therefore, this utility model solves the problem of poor therapeutic effect of LED therapy in existing spectral therapy technologies.

[0040] In addition, this utility model also provides a lamp, which includes the above-mentioned LED device. In the lamp, since the LED device is provided with an independent sub-accommodating groove, and different chip groups are distributed in the independent sub-accommodating groove, and fluorescent colloid 50 is provided in each of them, and the lens part 51 protruding from the sub-accommodating groove of the fluorescent colloid 50 is adjusted, the brightness of light of different wavelengths of the LED device is consistent, thereby ensuring the therapeutic effect of the lamp.

[0041] In the description of this specification, the references to terms such as "one embodiment," "some embodiments," "example," "specific example," or "some examples," etc., indicate that a specific feature, structure, material, or characteristic described in connection with that embodiment or example is included in at least one embodiment or example of the present invention. In this specification, the illustrative expressions of the above terms do not necessarily refer to the same embodiment or example. Furthermore, the specific features, structures, materials, or characteristics described may be combined in any suitable manner in one or more embodiments or examples.

[0042] The embodiments described above are merely illustrative of several implementations of this utility model, and while the descriptions are relatively specific and detailed, they should not be construed as limiting the scope of this utility model patent. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of this utility model, and these all fall within the protection scope of this utility model. Therefore, the protection scope of this utility model patent should be determined by the appended claims.

Claims

1. An LED device, characterized by, The device includes a support and a first chip group, a second chip group, and a third chip group disposed within the support. The support has a receiving groove, and the receiving groove is divided into three independent sub-receiving grooves by two parallel partitions. The first chip group, the second chip group, and the third chip group are respectively placed at the bottom of the sub-receiving grooves. Multiple fluorescent colloids are sequentially covered on the first chip group, the second chip group, and the third chip group. All the fluorescent colloids at least partially protrude from the sub-receiving grooves to form lens portions. The chip in the first chip group is a first low blue light chip. The fluorescent colloid covering the first chip group contains cyan phosphor and yellow-green phosphor, so that the first chip group area of ​​the bracket emits blue light, cyan light or yellow-green light. The second chip group includes a red light chip, a first near-red light chip, and a second near-red light chip. The fluorescent colloid covering the second chip group is transparent, so that the second chip group area of ​​the bracket emits red light within a preset wavelength range. The chip in the third chip group is a second low blue light chip, and the fluorescent colloid covering the third chip group contains yellow phosphor so that the third chip group area of ​​the bracket emits golden light.

2. The LED device of claim 1, wherein, The accommodating groove has a circular cross-section. The partition divides the accommodating groove into a first sub-accommodating groove, a second sub-accommodating groove, and a third sub-accommodating groove. The second sub-accommodating groove is rectangular and centrally located. The first sub-accommodating groove and the second sub-accommodating groove are crescent-shaped and symmetrically located on both sides of the second sub-accommodating groove.

3. The LED device of claim 2, wherein, The first chipset, the second chipset, and the third chipset are respectively disposed at the bottom of the first sub-accommodating slot, the second sub-accommodating slot, and the third sub-accommodating slot.

4. The LED device of claim 1, wherein, The cross-sectional area of ​​the receiving groove gradually increases from one end near the bottom of the receiving groove to the other end.

5. The LED device of claim 1, wherein, The red light chip, the first near-red light chip, and the second near-red light chip are all located on the same anode plate, and the red light chip, the first near-red light chip, and the second near-red light chip are respectively connected to an independent cathode plate via wires.

6. The LED device of claim 5, wherein, The outer contours of all the lenses are different to adjust the brightness of the light emitted by each region of the first chip group, the second chip group, and the third chip group.

7. A luminaire characterized by, Includes the LED device according to any one of claims 1 to 6.